Cytokinetics

About:

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

Top Investors: Royalty Pharma, Duke University, Deerfield, Mayfield Fund, Vulcan

Description:

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.

Total Funding Amount:

$1.76B

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

1998-01-01

Contact Email:

medicalaffairs(AT)cytokinetics.com

Founders:

James Sabry, James Spudich, Lawrence Goldstein, Ronald Vale

Number of Employees:

251-500

Last Funding Date:

2024-05-22

IPO Status:

Public

Industries:

Biopharma

Biotechnology

Health Care